BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18163112)

  • 1. [Extended D3 lymphadenectomy in surgical treatment of stomach cancer].
    Khvastunov RA; Shereshkov AIu; Shirokov OV; Ivanov AI; Mudryĭ AIu; Danilov SP
    Khirurgiia (Mosk); 2007; (12):34-8. PubMed ID: 18163112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network.
    Verlato G; Roviello F; Marchet A; Giacopuzzi S; Marrelli D; Nitti D; de Manzoni G
    Ann Surg Oncol; 2009 Mar; 16(3):594-602. PubMed ID: 19118437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
    Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
    Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
    Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
    Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immediate results of surgical treatment of stomach cancer].
    Arutiunian GA; Kryzhanovskiĭ AI; Selin SM; Arutiunian VA; Polikarpov SA
    Khirurgiia (Mosk); 2003; (7):55-8. PubMed ID: 12926341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment on different modes of lymphadenectomies in the treatment for early gastric cancer].
    Huang BJ; Lu C; Xu HM
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):293-6. PubMed ID: 17760258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-extended (D3) lymphadenectomy in advanced gastric cancer.
    Roviello F; Pedrazzani C; Marrelli D; Di Leo A; Caruso S; Giacopuzzi S; Corso G; de Manzoni G
    Eur J Surg Oncol; 2010 May; 36(5):439-46. PubMed ID: 20392590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenectomy in gastrointestinal surgery for malignancy.
    Jakab F; Baranyai L; Baranyai Z; Országh A; Mayer A; Bajtai A
    Acta Chir Hung; 1997; 36(1-4):141-2. PubMed ID: 9408319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D2 lymphadenectomy for surgical and combined treatment of the gastric cancer].
    Skoropad VIu; Berdov BA
    Khirurgiia (Mosk); 2010; (4):26-9. PubMed ID: 20517234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrences after surgical treatment of early (pT1) cancer of the stomach: laws of development, extended lymphadenectomy in prophylaxis of recurrences].
    Skoropad VIu; Berdov BA
    Khirurgiia (Mosk); 2007; (1):43-8. PubMed ID: 17426689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors.
    Marrelli D; Pedrazzani C; Neri A; Corso G; DeStefano A; Pinto E; Roviello F
    Ann Surg Oncol; 2007 Jan; 14(1):25-33. PubMed ID: 17024558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of a signal lymph node in surgical treatment of gastric cancer].
    Sedov VM; Rybakova MG; Iaitskiĭ AN; Danilov IN; Mel'nikov OR; Grozov RV; Alekseev DA
    Vestn Khir Im I I Grek; 2009; 168(2):18-21. PubMed ID: 19514386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.
    Li C; Kim S; Lai JF; Oh SJ; Hyung WJ; Choi WH; Choi SH; Zhu ZG; Noh SH
    Eur J Surg Oncol; 2009 Jul; 35(7):709-14. PubMed ID: 18455906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stomach cancer metastasizing to the para-aortic lymph nodes: possibilities of surgical treatment].
    Abdikhakimov AN; Davydov MI; Ter-Ovanesov MD; Stilidi IS; Marchuk VA; Dykhno AIu
    Vopr Onkol; 2003; 49(2):209-16. PubMed ID: 12785207
    [No Abstract]   [Full Text] [Related]  

  • 19. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).
    Tsujinaka T; Sasako M; Yamamoto S; Sano T; Kurokawa Y; Nashimoto A; Kurita A; Katai H; Shimizu T; Furukawa H; Inoue S; Hiratsuka M; Kinoshita T; Arai K; Yamamura Y;
    Ann Surg Oncol; 2007 Feb; 14(2):355-61. PubMed ID: 17146738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.